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Abstract
Background: In early 2001 Australia experienced a sudden reduction in the availability of heroin
which had widespread effects on illicit drug markets across the country. The consequences of this
event, commonly referred to as the Australian 'heroin shortage', have been extensively studied and
there has been considerable debate as to the causes of the shortage and its implications for drug
policy. This paper aims to investigate the presence of these epidemic patterns, to quantify the scale
over which they occur and to estimate the relative importance of the 'heroin shortage' and any
epidemic patterns in the drug markets.
Method: Key indicator data series from the New South Wales illicit drug market were analysed
using the statistical methods Principal Component Analysis and SiZer.
Results: The 'heroin shortage' represents the single most important source of variation in this
illicit drug market. Furthermore the size of the effect of the heroin shortage is more than three
times that evidenced by long-term 'epidemic' patterns.
Conclusion: The 'heroin shortage' was unlikely to have been a simple correction at the end of a
long period of reduced heroin availability, and represents a separate non-random shock which
strongly affected the markets.
Background
In January 2001 injecting drug users (IDUs), law enforce-
ment and treatment agencies noticed a sudden and unex-
pected reduction in the availability of heroin in New
South Wales (NSW), Australia [1,2]. The reduction in her-
oin supply had a significant effect on other illicit drug
markets, as IDUs initially increased their consumption of
cocaine and amphetamines [3]. This phenomenon has
become known as the Australian 'heroin shortage' (or
'heroin drought'). The shortage was associated with signif-
icant changes in a variety of indicators of criminal activity
[4], reductions in the prevalence of heroin and other drug
overdoses [5], and in IDU treatment-seeking activity [6].
The wide attention which this 'heroin shortage' gained
and its impact on a wide range of indicator and sentinel
data sets reinforced the significance of the phenomenon
(see for example [7]).
There has, however, been some debate as to whether or
not the 'shortage' represents a sudden and unexpected
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reduction in the availability of heroin or the end of a
widespread 'glut' of heroin experienced in major Austral-
ian markets in the two years preceding the shortage [8].
Dietze and Fitzgerald (2002) have argued that the late
1990s, when heroin markets in Australia were rapidly
expanding, represented a heroin "glut" and that the
"shortage" was simply a return to levels of availability that
prevailed before this heroin "glut". While acknowledging
that there had been a sharp relative reduction in heroin
supply, they suggested that its magnitude had been exag-
gerated by drug market monitoring put in place in the mid
1990s. Although there has been considerable insight into
the probable causes of the shortage [9], the debate is in
one sense academic, since it is not clear whether it could
occur again at some future time, but the question remains
important for policy discussion and policy making regard-
ing Australian illicit drug markets. The question of
whether a sudden collapse is a natural part of the final
phase of an 'epidemic' cycle in illicit drug markets, or
whether such a sudden collapse must be sparked by inde-
pendent events is crucial to our understanding of the driv-
ing forces in the illicit drug market. Information about
such a phenomenon also enables drug policy makers to
be better prepared for future collapses (if they are inevita-
ble) or to better isolate their causes (if they are caused by
independent events which could potentially be manipu-
lated for the purposes of supply reduction).
In this paper we investigate this important question using
two statistical methods: principal component analysis
and SiZer analysis. Principal component analysis [10]
enables us to contrast different periods of time in illicit
drug market data, while the SiZer analysis [11] identifies
statistically significant periods of change over different
time scales in key data series. By integrating these two
analyses we can answer the question of whether or not
epidemic cycles such as those described by Dietze and Fit-
zgerald exist in Australian illicit drug markets. Further-
more we identify the scale over which significant changes
occur in data series which show evidence of epidemic
behaviour, and compare the relative importance of epi-
demic and non-random shock patterns to the long-term
development of the illicit drug markets.
Methods
Data
Principal component analysis and the SiZer were applied
to 17 key indicator data series from NSW (Table 1). These
data series were identified by key informants and prior
analysis as being associated with drug markets [12]. The
data series represent counts of all events in NSW, and
there were no missing values. The data series were col-
lected over 66 months from January 1997 to June 2002.
These data series were collected prospectively at their
administering agencies, but were not used to identify the
time of onset of the heroin shortage, since there is a 6–12
month delay between collection of the data and its analy-
sis. If the range of different data series varies considerably,
it is standard practice [10] to scale or standardise the orig-
inal data. This was done by subtracting from each series its
own long-term mean, and dividing by its own series-spe-
cific standard deviation.
Principal component analysis
PCA explains structure in data by identifying those direc-
tions in multivariate data sets which contain the most rel-
Table 1: data series used for the study
Data series Source
Heroin possession offences Bureau of Crime Statistics and Research (BOCSAR)
Cocaine possession offences BOCSAR
Amphetamine possession offences BOCSAR
Prostitution offences BOCSAR
Ambulance attendances to heroin overdose NSW Ambulance Service
Methadone maintenance treatment registrations Pharmaceutical Services Branch (PSB)
Methadone maintenance treatment new registrations PSB
Heroin calls of concern Alcohol and other Drug Information Service (ADIS)
Cocaine calls of concern ADIS
Amphetamine calls of concern ADIS
Heroin overdose deaths Division of Analytic Laboratories
Amphetamine overdose attendances to accident and emergency departments NSW Health
Robbery without a weapon BOCSAR
Steal from Motor Vehicle BOCSAR
Drug psychosis attendances at accident and emergency departments NSW Health
Robbery with a weapon not a firearm BOCSAR
Break and enter dwelling BOCSAR
For more detail on each of these data series see [12]BMC Public Health 2006, 6:200 http://www.biomedcentral.com/1471-2458/6/200
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evant information. This process often reveals
relationships in data that were not previously suspected,
allowing interpretations that would not otherwise be pos-
sible. The directions are ordered by the amount of vari-
ance they explain, starting with the direction that explains
the largest single contribution to variance. The method is
classical in origin ({Lattin, 2003 #264} [13]). In essence,
PCA extracts the statistically uncorrelated data directions
as the eigenvectors of the covariance matrix of the original
data, and orders them in descending order of magnitude
of their corresponding eigenvalues. The extent to which
each variable in the original data contributes to a particu-
lar rotated direction is determined by the components of
these eigenvectors, called the 'loadings'. Variables whose
loadings are of a different sign in the same eigenvector can
be said to be contrasted against one another in the rotated
directions calculated by PCA. For the 17 key indicator data
sets, where the dimensions correspond to time points –
here subsequent months – the loadings represent periods
of time with constant behaviour from clusters or runs of
loadings similar in sign and magnitude.
Calculation of principal components
PCA was carried out in Matlab 6.1. To calculate principal
components we treated the data as a multivariate data set
of 66 components or dimensions and 17 observations, i.e.
we have n = 17 and p = 66. With the data in this format,
the months form the 'variables' on which we wish to iden-
tify the loadings, and each data series represents one
observation of these 66 variables. This enables us to assign
the months into partitions according to their loadings.
Because PCA cannot identify more eigenvectors than there
are observations, we obtain at most 17 eigenvectors. To
obtain an interpretation based on the principal compo-
nent directions, we examine the loadings (the values of
components in the eigenvectors) for 'runs', 'jumps' and
'isolated points'. Isolated points if large indicate outliers
in a particular component. Runs are (uninterrupted)
sequences of values along the components which do not
differ much from their neighbouring points, and therefore
indicate that there is not much change along these com-
ponents. Jumps between successive points signify change.
Runs separated by jumps give rise to clusters which
describe the relationship of the data. Because these clus-
ters were not identified using a measure of distance per se,
we refer to them as partitions for the remainder of this
paper.
The SiZer
SiZer (Significance of Zero crossings of the derivative) is a
method for the statistical analysis of rates of change in a
data series over a range of different scales. SiZer applies a
family of local linear smoothers (with Gaussian kernel
weights) to the data series, varying the 'smoothing param-
eter' or 'bandwidth' continuously and presenting the
results for discrete points in the range of possible band-
widths. In this analysis, a larger bandwidth represents a
longer time frame over which changes in the series were
studied. The rate of change (derivative) of each kernel
density estimator is calculated, and a plot created at each
bandwidth which indicates pictorially whether the deriv-
ative is significantly different from zero at each point on
the chart. If the derivative is significantly different and
increasing, the region over which this occurs is coloured
blue; if significantly different and decreasing, the region is
coloured red; and if not significantly different to zero (i.e.
level) the region is coloured purple. Regions with insuffi-
cient amount of data are coloured grey. A two-dimen-
sional plot shows the regions of increase and decrease as
a function of time (the x-axis) and bandwidth (the y-axis)
(see, for example, Figure 5). SiZer tests of the significance
of slopes over the entire data set are adjusted for the addi-
tional type I error in multiple tests {Chaudhuri, 1999
#243}. Serial dependence is not incorporated into the
SiZer model as presented here, but the authors have previ-
ously estimated that there is only limited serial depend-
ence in the heroin deaths series {Degenhardt, 2004
#245}. Serial dependence in the cocaine possession
offences data has been estimated as a positive AR(1) term
that will only inflate variance of regression parameter esti-
mates by about 11% {Degenhardt, 2005 #233}. Serial
dependence will therefore have a limited effect on the sig-
nificance of results presented here.
SiZer was applied to the heroin overdose deaths and the
cocaine possession offences data using software available
from Marron et al [11] and implemented in Matlab 6.1.
These are two iconic data series representing major struc-
tural phenomena in the illicit drug markets which have
previously been studied using time series methods [14,5].
Although ideally cocaine markets would be better studied
using measures of the health effects of cocaine which are
independent of police activity, no such health indicators
exist, and state wide data on possession offences were
deemed the next best data series for objective assessment
of cocaine market activity [15].
Results
The entire data set is shown in Figure 1 in parallel plot
form (i.e. as a combined plot of all 17 data series with the
x-axis as the months, and different series displayed in dif-
ferent colours) [16]. Here each line corresponds to a single
data series, and each data series is distinguishable by a
unique colour. The left-hand plot contains 17 data series
and shows a clear pair of outlier series (break and enter
dwelling and steal from motor vehicle) while the right hand
plot shows the dataset with these two series removed. The
remaining 15 data series clearly span a range of scales, and
excluding the two outlying series will not remove the
dependence of the variance structure on individual series,BMC Public Health 2006, 6:200 http://www.biomedcentral.com/1471-2458/6/200
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indicating that it is better to standardise all data series
than to remove outliers.
The standardised data is shown in Figure 2, and shows
some evidence of a peak or change in behaviour at about
month 50 (the widely accepted onset point of the heroin
shortage [17]) and limited curvature across the plot. In
this form the data is difficult to interpret clearly.
The scree plot for the first 17 principal components is
shown in Figure 3. The first principal component explains
45% of the variance, while the second explains 13% of the
variance. Subsequent principal components clearly
explain only small proportions of the variance. The first 6
principal components explain 85% of the variability in
the standardised data.
Figure 4 shows the loadings of the 66 months for the first
and second principal components.
We assign the loadings into two distinct groups by visual
inspection, as shown in Table 2. For principal component
1 there is a run of similar loadings up to month 49, where
a jump occurs to a second set of loadings with similar val-
ues. This jump represents the point of division of the data
into two partitions. Principal component 2 has a run of
similar loadings up until month 24, followed by a jump
to a new cluster with similar loadings. At month 50 there
is another jump, with the loadings after this having simi-
lar values to those before month 24. This suggests three
partitions, separated from one another by jumps at
months 25 and 50.
Depicted graphically (Figure 4), there is clear evidence of
clustering in the loadings. Principal component 1 pro-
Parallel coordinate plots of complete illicit drug market data Figure 1
Parallel coordinate plots of complete illicit drug market data.BMC Public Health 2006, 6:200 http://www.biomedcentral.com/1471-2458/6/200
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vides a contrast between pre- and post- heroin shortage
months, while principal component 2 provides a contrast
between those months at the peak of an epidemic cycle
(months 25 to 49) and those months at the troughs (the
remainder). The structure of these partitions is very clear,
with very few observations which cannot be placed imme-
diately. Since principal component 1 explains almost 4
times as much variance as principal component 2, the
foremost interpretation of the variation in the data is that
obtained from principal component 1. Principal compo-
nent 2 represents a weaker explanation of the data series'
variation. We conclude that in this data set the contrast
between pre- and post-shortage behaviour is of much greater
significance than the contrast between peaks and troughs in the
data series. The heroin shortage is clearly shown by PCA to
be the single largest structural driver of variability in the
data set.
The results of applying SiZer to the heroin overdose death
data are shown in Figure 5. The topmost plot gives a 'fam-
ily overlay' of the smoothed curves for kernel smoothers
estimated with a range of different bandwidths, with the
thick black curve representing the 'best fit' to these fami-
lies of smoothers. The lower plot shows regions of statis-
tically significant first derivatives of the smoothers,
presented by bandwidth. The 'best fit' smoother is shown
as a black line. In this plot regions of statistically signifi-
cant increase in the smoothed curve are shown in blue,
areas where the slope is zero are shown in purple, and
areas of statistically significant decrease are shown in red.
The first derivative for the 'best fit' smoother suggests a sig-
nificant increase in deaths (months 5 – 12), which pla-
teaus (months 12 – 25) and then shows a significant
decrease (months 25 – 35). This represents a broad pat-
tern of increase and decrease in a 30 month period
between May 1997 and November 1999. There is another
Parallel coordinate plot of the standardised data Figure 2
Parallel coordinate plot of the standardised data.BMC Public Health 2006, 6:200 http://www.biomedcentral.com/1471-2458/6/200
Page 6 of 10
(page number not for citation purposes)
significant decrease in deaths between months 48 and 55
(December 2000 and July 2001), corresponding with the
point of onset of the heroin shortage. The bandwidth of
this best fit is approximately 2 (since log10(2) = 0.3), rep-
resenting a Gaussian kernel calculated in a neighbour-
hood of approximately 8 months. Larger bandwidths (for
example, a bandwidth of 10) show a longer period of
increase in the first half of the data series, and a statisti-
cally significant decrease for the remainder of the series.
The statistically significant decrease between months 48
and 55 is significant at all bandwidths for which data density
is sufficient to estimate significance. Evidence for the heroin
shortage prevails at small bandwidths where the long-
term decline in the data series is no longer evident, sug-
gesting it is a separate phenomenon from the 'epidemic'
cycle evident at other points of the data series and over
wider bandwidths of smoothing.
Table 2: months assigned to the partitions for principal components 1 and 2
Partition 1 Partition 2 Partition 3
Principal component 1 All months after month 49 All other months before month 49 -
Principal component 2 All months before month 25 All months between 25 and 49 all months between 50 and 61
Scree plot of the first 16 and the first 6 principal components Figure 3
Scree plot of the first 16 and the first 6 principal components.BMC Public Health 2006, 6:200 http://www.biomedcentral.com/1471-2458/6/200
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Figure 6 shows SiZer plots for the cocaine possession
offence data. The 'best fit' smoother suggests the presence
of a small increase between months 5 and 12 (May 1997
and December 1997) and a further increase between
months 45 and 51 (September 2000 and March 2001),
which reverses after month 60. Over larger bandwidths
the specific increase between months 45 and 51 disap-
pears, merging into a long period of growth in the data
series. Again, the change in the data series at month 49 is
evident in as narrow a timeframe as 6–8 months, where it
represents one of two expansions in the scale of the mar-
ket. This expansion reverses within 6–8 months. The
smoother suggests two temporary expansions in the mar-
ket, one between months 5 and 12 which never reverses,
and one at the time of the heroin shortage which levels off
after 6–8 months and declines 6–8 months later. This pat-
tern of behaviour is more consistent with the observed
data than is the observation of a consistent long-term
expansion obtained from a view over wider bandwidths.
Both of these SiZer plots provide clear evidence for a sud-
den change in the period July 2000 – February 2001,
observable separately from long-term trends when viewed
on a narrow timeframe. The nature of the change and its
long term behaviour is consistent with other time series
analyses of these data [14] and [5].
Discussion
Principal component analysis of key indicator data from
NSW shows clearly that the first two principal compo-
nents contain distinct and distinguishable information.
The first of these principal components, explaining 45%
of the variability in the data, represents a contrast between
pre- and post- heroin shortage time points. The second of
these, explaining 13% of the variability in the data, repre-
Loadings for the first 2 principal components of the standardised illicit drug market data Figure 4
Loadings for the first 2 principal components of the standardised illicit drug market data.BMC Public Health 2006, 6:200 http://www.biomedcentral.com/1471-2458/6/200
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sents a contrast between months at the peak of the heroin-
market data series (between 1999 and 2001) and months
in the 'trough' either side of this peak. The ordering of
these principal components, their clear interpretation and
the absence of correlation between them is strong evi-
dence for the interpretation of the heroin shortage as an
event that occurred separately of long-term cycles in Aus-
tralian illicit drug markets, and which accounted for a
great deal more variability in the data than other variabil-
ity which happened over a longer term.
It is unlikely that the heroin shortage represented a natu-
ral 'correction' to the illicit drug market which occurred
after the end of a long period of decline in heroin markets,
since the principal component representing the shortage
is uncorrelated with the principal component represent-
ing the long-term trend in the market, and because the
shortage explains four times as much variability in the
data as does the phenomenon which it might be supposed
to be 'correcting'. The SiZer analysis presents further evi-
dence of the existence and placement of the shortage, and
its importance relative to long-term trends in the data. In
the two series presented here the period surrounding the
heroin shortage is the only period in the data in which a
significant change is visible over all bandwidths for which
there is sufficient data to estimate significance. It is also
clearly evident as a separate phenomenon from longer-
term trends (such as earlier increases and decreases in the
level of the data series) in the 'best fit' smoother obtained
from the SiZer.
SiZer plots for heroin overdose deaths Figure 5
SiZer plots for heroin overdose deaths.BMC Public Health 2006, 6:200 http://www.biomedcentral.com/1471-2458/6/200
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These analyses, based on the twin methods of extraction
of lower-dimensional data on the basis of maximum var-
iability and uncorrelatedness (PCA) and scatterplot
smoothing over a wide range of smoothing choice (the
SiZer) both support the theory that the heroin shortage
was a real, identifiable event in Australian illicit drug mar-
kets. The analyses also provide evidence that the heroin
shortage which was not directly related to long-term drug
market trends and was the single largest phenomenon in
the illicit drug market over the 6 year period studied.
These findings have several important ramifications for
drug market policy. Firstly, to the best of the authors'
knowledge, there is no other study which shows that a
non-random shock, possibly deliberately induced by drug
market factors, can be of considerably greater magnitude
than the natural cycles in the market. Secondly, this study
confirms mathematically the commonly-held theory that
drug markets work in cycles, and gives some evidence of
the scale over which this cycle is working in modern Aus-
tralia (about 6 – 8 years from trough to trough). Although
it is likely that more extensive harm reduction policies
(such as readily available methadone treatment) and bet-
ter supply reduction policies (such as high level interdic-
tion activities) may change the long-term patterns in the
markets, this finding may help policy-makers to predict
future trends in the public health consequences of illicit
drug use, and may help inform long-term predictions of
numbers of drug users. Incorporation of this scale into
historical data on heroin overdose deaths (for example)
may enable long-term changes in the scale of the epidemic
to be estimated, leading to more accurate future predic-
tions of heroin market movement. Finally, inasmuch as
the scale of heroin markets may be related to the numeri-
cal behaviour of major indicator data series, drug markets
may be subject to non-random influence at their peak as
well as when they are heading towards their trough, giving
SiZer plot for cocaine possession offences Figure 6
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some comfort to those who believe that drug markets are
controllable even when they are at their peak
Conclusion
Existing models of drug markets often suggest that they
are beyond government or social control, and that the
high rates of death and illness caused by rampant heroin
markets at their peak are an inevitable and unavoidable
consequence of these markets. The findings of this paper
suggest that this is not the case; that even at their peak
these markets may be vulnerable to intervention; and that
drug market policy settings can be manipulated to prevent
unnecessary death and illness in young Australians.
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